基础医学与临床 ›› 2011, Vol. 31 ›› Issue (3): 312-315.

• 临床园地 • 上一篇    下一篇

治疗策略及治疗反应对小细胞肺癌预后影响的多因素分析

邵亚娟1,宁晓红2,王毓洲2   

  1. 1. 中国医学科学院 北京协和医学院 北京协和医院
    2. 中国医学科学院北京协和医学院北京协和医院肿瘤内科
  • 收稿日期:2010-08-27 修回日期:2010-12-29 出版日期:2011-03-05 发布日期:2011-03-14
  • 通讯作者: 邵亚娟 E-mail:xiaoyaslvln@sina.com

Effect of Treatment Tragedy and Response on Survival of Small Cell Lung Cancer-Multivariate Analysis

SHAO Ya-juan 1,NING Xiao-hong 2,WANG Yu-zhou 2   

  1. 1. PUMC Hospital, CAMS & PUMC
    2. Dept of Oncology, PUMC Hospital, PUMC & CAMS
  • Received:2010-08-27 Revised:2010-12-29 Online:2011-03-05 Published:2011-03-14
  • Contact: SHAO Ya-juan E-mail:xiaoyaslvln@sina.com

摘要: 目的 探讨不同治疗策略及治疗反应对小细胞肺癌(SCLC)预后的影响。方法 收集2002年1月~2010年1月住院化疗的小细胞肺癌患者,回顾分析其治疗过程,并对其随访。对可能的危险因素进行单因素分析,P<0.1的因素进入Cox风险比例回归模型。结果 住院接受化疗的小细胞肺癌患者共76例,局限期43例,1、2和5年生存率分别为81%、56%和21%;广泛期33例,1和2年生存率分别为59%和24%。单因素分析放化疗联合治疗、一线化疗最佳疗效为有效(CR+PR)为生存相关因素;接受手术治疗为局限期患者生存相关因素。Cox风险比例回归模型多因素分析,上述因素均为独立相关因素。结论 放化疗联合治疗、提高一线方案疗效、局限期早期患者接受手术治疗可能会提高患者生存。

关键词: 小细胞肺癌, 治疗, 预后, 多因素分析

Abstract: Objective To explore the effect of different treatment and different response on the prognosis of small cell lung cancer. Method Collect patients diagnosed as small cell lung cancer and admitted to our department to receive chemotherapy between Jan 2002 to Jan 2010, review their records and do follow-up. Analyze the potential variables and only factors associated with survival with a P value less than o.1 in univariate analysis were introduced into the Cox regression model. Results 76 cases were included in this study. For local stage, 1-year,2-year, and 5-year survival rate are 81%,56%,21%,respectively. For extend stage,1-year,2-year survival rate are 59%,24%. Chemotherapy combined with radiotherapy, CR+PR obtained in first-line chemotherapy are associated with survival. For local stage, complete resection is associate with survival. In Cox regression, the variables above are all independent factors of survival. Conclusion Chemotherapy combined with radiotherapy, increasing the effectiveness of first-line regimen, and complete resection for selected local stage patient may be the way to improve survival of small cell lung cancer patients.

中图分类号: